You are here: Industry Insights > Australia

News List

Australia’s star vaccine maker not immune to virus anxiety: Analysis expresspharma
October 29, 2020
A promise to supply Australia's 25 million people with a coronavirus vaccine, if one becomes available, has boosted CSL's profile.
Australia enters $1.2bn Covid-19 vaccine supply agreement pharmaceutical-technology
September 17, 2020
The Government of Australia has signed a supply and production agreement valued at A$1.7bn ($1.2bn) to potentially offer a free Covid-19 vaccine to its citizens next year.
Australia signs deal for AstraZeneca’s Covid-19 vaccine pharmaceutical-technology
August 20, 2020
The Australian Government has signed an agreement with AstraZeneca for the supply of the company’s Covid-19 vaccine candidate developed by the University of Oxford.
Australia’s TGA approves remdesivir as first Covid-19 treatment pharmaceutical-technology
July 14, 2020
The Therapeutic Goods Administration (TGA) of Australia has awarded provisional approval for the use of Gilead Sciences’ remdesivir (Veklury) to treat Covid-19 patients, marking the first authorisation of treatment for this disease in the country.
Australia to test COVID-19 vaccine prnasia
April 15, 2020
The first COVID-19 vaccine to be tested outside of the USA, and only the third vaccine clinical trial in the world, will be conducted by Australia's largest Phase 1 clinical trials specialist Nucleus Network.
Australia grants Patent to Krystal Biotech biospectrumasia
October 08, 2019
This patent covers pharmaceutical compositions comprising KB103, as well as to medical uses thereof, e.g., in the treatment of wounds, disorders, or diseases of the skin, particularly those found in epidermolysis bullosa patients.
FDA takes first action under new international collaboration with Australia and Canada worldpharmanews
September 18, 2019
The U.S. Food and Drug Administration is announcing Project Orbis, an initiative of the FDA Oncology Center of Excellence (OCE).
Australia develops new technology for neonatal care biospectrumasia
September 06, 2019
Research breakthrough to safely monitor pre-term babies
Australia's Propanc Biopharma gets US Patent biospectrumasia
August 25, 2019
Propanc Biopharma Receives Granted US Patent Covering Additional Composition Claims for PRP.
Mylan and Biocon launch first Trastuzumab Biosimilar, Ogivri, in Australia expresspharma
August 02, 2019
Biocon and Mylan NV have announced the launch of Ogivri (trastuzumab), a biosimilar to Herceptin (trastuzumab), in Australia for treatment of HER2-overexpressing breast cancer and metastatic stomach cancer (gastric or gastroesophageal junction adenocarcin

Previous page 1 2 3 4 5 6 Next page